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Abstract
Background: Alcohol use disorders (AUDs) in people living with HIV/AIDS (PLWH) are a significant impediment to
achieving virological control. HIV non-suppression in PLWH with AUDs is mainly attributable to sub-optimal
antiretroviral therapy adherence. Sub-optimal adherence makes control of the epidemic elusive, considering that
effective antiretroviral treatment and viral suppression are the two key pillars in reducing new infections.
Psychological interventions have been proposed as effective treatments for the management of AUDs in PLWH.
Evidence for their effectiveness has been inconsistent, with two reviews (2010 and 2013) concluding a lack of
effectiveness. However, a 2017 review that examined multiple HIV prevention and treatment outcomes suggested
that behavioural interventions were effective in reducing alcohol use. Since then, several studies have been published
necessitating a re-examination of this evidence. This review provides an updated synthesis of the effectiveness of
psychological interventions for AUDs in PLWH.
Methods: A search was conducted in the following databases: PubMed, Cochrane Central Register of Trials (CENTRAL),
MEDLINE (Ovid), EMBASE, PsychInfo (Ovid) and Clinical trials.gov (clinicaltrials.gov) for eligible studies until August 2018
for psychotherapy and psychosocial interventions for PLWH with AUDs. Two reviewers independently screened titles,
abstracts and full texts to select studies that met the inclusion criteria. Two reviewers independently performed data
extraction with any differences resolved through discussion. Risk of bias was assessed by two independent reviewers
using the Cochrane risk of bias tool, and the concordance between the first and second reviewers was 0.63 and
between the first and third reviewers 0.71. Inclusion criteria were randomised controlled trials using psychological
interventions in people aged 16 and above, with comparisons being usual care, enhanced usual care, other active
treatments or waitlist controls.
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Results: A total of 21 studies (6954 participants) were included in this review. Studies had diverse populations
including men alone, men and women and men who had sex with men (MSM). Use of motivational interviewing
alone or blended with cognitive behavioural therapy (CBT) and technology/computer-assisted platforms were
common as individual-level interventions, while a few studies investigated group motivational interviewing or
CBT. Alcohol use outcomes were all self-report and included assessment of the quantity and the frequency of
alcohol use. Measured secondary outcomes included viral load, CD4 count or other self-reported outcomes. There
was a lack of evidence for significant intervention effects in the included studies. Isolated effects of motivational
interviewing, cognitive behavioural therapy and group therapy were noted. However for some of the studies that
found significant effects, the effect sizes were small and not sustained over time. Owing to the variation in
outcome measures employed across studies, no meta-analysis could be carried out.
Conclusion: This systematic review did not reveal large or sustained intervention effects of psychological interventions
for either primary alcohol use or secondary HIV-related outcomes. Due to the methodological heterogeneity, we were
unable to undertake a meta-analysis. Effectiveness trials of psychological interventions for AUDs in PLWH that include
disaggregation of data by level of alcohol consumption, gender and age are needed. There is a need to standardise
alcohol use outcome measures across studies and include objective biomarkers that provide a more accurate measure
of alcohol consumption and are relatively free from social desirability bias.
Systematic review registration: PROSPERO CRD 42017063856.
Keywords: Alcohol, HIV, Systematic review, Psychological, Motivational, Cognitive, Screening, Brief, Interventions,
Background
It is estimated that 30–50% of people living with HIV
(PLWH) have alcohol use disorders (AUDs) and conse-
quently tend to have unfavourable HIV treatment out-
comes [1, 2]. Viral load suppression and testing-and-
treating are key targets of the UNAIDS 90-90-90 goals,
aimed at eliminating HIV by 2030 [2]. Alcohol use is asso-
ciated with risky sexual behaviour, sexually transmitted in-
fections and condomless sex, which are all associated with
increased transmission of HIV [3–6]. Alcohol use is also
associated with reduced uptake of pre-exposure prophy-
laxis (PrEP) and post-exposure prophylaxis (PEP) [3–6],
delayed HIV testing, treatment initiation, reduced adher-
ence to antiretroviral therapy (ART), more treatment in-
terruptions and lack of viral suppression [2]. In addition,
alcohol use is associated with traffic accidents, intimate
partner violence, liver disease and cancers, which are all
associated with premature deaths [7–11].
Evaluation of the extent alcohol use in most settings is
usually done through screening with self-report question-
naires and clinical examination. Rarely are laboratory inves-
tigations, such as alcohol biomarkers, employed. Alcohol
self-report assessments tools include the Cut-Annoyed-
Guilty-Eye-opener (CAGE), which is a 4-question screener
particularly suited for the presence of dependency and the
Alcohol Use Disorders Identification Test (AUDIT), which
is a 10-question instrument developed by the World Health
Organization (WHO) with scores ranging from 0 to 40
[11–13]. A short form of the AUDIT, the AUDIT-C, is also
increasingly used to reduce administration time [14]. Bio-
logical measures of alcohol use include blood alcohol con-
centration (BAC) or surrogates such as liver transaminases,
such as gamma glutamyl transaminase (GGT) and mean
corpuscular volume (MCV), which are non-specific as they
may be changed by liver disease and haematological disease.
BAC is, however, able to assess current use but is often un-
available in many settings. Newer biomarkers such as phos-
photidyl ethanol (PEth) and ethyl glucuronide (EtG) are
promising although the costs may be prohibitive, especially
in low-resource settings [15].
Recommended treatments for AUDs include evidence-
based therapies such as motivational interviewing, cogni-
tive behavioural therapy, risk reduction, problem-solving
techniques, case management and adjunct pharmaco-
logical interventions, especially where there is evidence
for dependence. Psychological interventions can be de-
livered in diverse formats, such as individual or group or
both. Treatment settings include hospital-based, com-
munity, primary care or emergency services [16]. Lately,
there has been an increase in the use of smartphones
and other mobile devices to deliver these interventions
[17], as they increase access in hard-to-reach popula-
tions. These technologies are also cost-effective [18, 19].
Given that adherence to ART is the single most import-
ant determinant of HIV treatment success, alcohol-
focused psychological interventions may significantly
improve HIV treatment outcomes [20]. Reviews of inter-
ventions that target adherence only, without control of
alcohol use, have been inconclusive, leading to calls for in-
terventions that target both adherence and problematic al-
cohol use [7, 21]. Psychological interventions need to be
tailored to address comorbid conditions, such as depres-
sion and anxiety, and other psychosocial sequelae (e.g.
stigma) that are implicated in poor ART adherence [21,
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22]. Psychological interventions may work by addressing
the stigma, including self-stigma that PLWH often face.
They may also work by assisting PLWH to acquire new
problem-solving skills that may be useful in dealing with
other life problems. However, the effectiveness of these in-
terventions may be limited by other unresolved psycho-
social challenges and the presence of cognitive
impairments (e.g. memory impairment) that can lead to
unintentional skipping of medication.
Currently, there are insufficient data on the effective-
ness of psychological interventions for AUDs in PLWH,
specifically with regard to the active ingredients of each
intervention, the dosing required, and the circumstances
under which they work [16]. It is thus essential that
these aspects be teased out in order for firm up treat-
ment recommendations. Brown et al. [16] called for effi-
cacious interventions to be developed and implemented
[16]. This systematic review synthesises current evidence
on the effectiveness of psychological and behavioural in-
terventions for AUDs in PLWH.
Objectives
This study aimed to systematically synthesise evidence
on the effectiveness of psychological interventions for al-
cohol use and HIV treatment outcomes in people living
with HIV/AIDS with AUDs.
Methods
The protocol of this review was registered with PROS-
PERO (CRD42017063856). The review is reported using
PRISMA guidelines [23].
Criteria for considering studies for this review
Types of studies
Studies included in the review were randomised controlled
trials, including where the control was a waiting list, and de-
signs that used a quasi-random allocation mechanism, such
as alternating assignment or next available treatment slot
controls.
Types of participants
Participants were PLWH aged 16 years and above who
had AUDs with or without other substance use and were
on ART at hospitals, clinics or in the community.
Types of intervention
The interventions included motivational interviewing,
motivational enhancement therapy, cognitive behav-
ioural therapy, community contingency therapy, group
therapy or any combination of the above that target
AUDs, with or without other substance use. Control
conditions included adherence counselling, pharmaco-
logical detoxification with benzodiazepines, anti-craving
medication and referral to psychiatric units or usual
care.
Types of outcome measures
Primary outcomes Primary outcomes included reduc-
tion in alcohol use, as measured by reduction in the fre-
quency and quantity of drinking, binge drinking and
heavy episodic drinking; reduction in score on the
AUDIT or AUDIT-C or CAGE; blood alcohol concen-
tration average (BAC); peak BAC; and surrogate markers
(e.g. GGT and transaminases), in studies that used psy-
chological interventions.
Frequency of alcohol use refers to the number of days
alcohol was consumed per a specified period and quan-
tity refers to the amount of alcohol consumed in a speci-
fied period.
Secondary outcomes Secondary outcomes were reduc-
tion in viral load, CD4 count change, quality of life (as
measured by the change in domains including physical
health, psychological health, social relationships and en-
vironmental health), risky sexual behaviour and ART
adherence.
Search methods for identification of studies
Electronic searches Two reviewers searched the
Cochrane Central Register of Trials (CENTRAL), MED-
LINE (Ovid) (1986-; EMBASE (EMBASE.com 1986-),
PsychInfo (Ovid) (1986-) and Clinical trials.gov (clinical-
trials.gov/) as at August 2018. There were no language
restrictions imposed on the search.
Searching other resources A search of the reference list
and bibliographic references of the articles selected for
inclusion in the review identified additional relevant arti-
cles. These were considered based on their titles and ab-
stracts. Other searches were done through a hand search
of authors who have published in psychological interven-
tions for AUDs.
The search terms included thread used in PUBMED, for
example, were as follows: (((((HIV[Title/Abstract] OR
AIDS[Title/Abstract] OR “human immunodeficiency vir-
us”[Title/Abstract] OR “acquired immunodeficiency syn-
drome”[Title/Abstract] OR “retroviral infection”[Title/
Abstract])) OR (HIV OR “Acquired Immunodeficiency
Syndrome”[MeSH Terms]))) AND (((Alcohol*[Title/Ab-
stract] OR drinking[Title/Abstract])) OR (“Alcohol-In-
duced Disorders” OR “Alcohol-Related Disorders” OR
“Alcohol Drinking”[MeSH Terms]))) AND ((“Psychosocial
intervention”[Title/Abstract] OR therapy[Title/Abstract]
OR psychotherapy[Title/Abstract] OR “motivational inter-
view”[Title/Abstract] OR “motivational interviewing”[Title/
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Abstract] OR “contingency management”[Title/Abstract]
OR “mutual help”[Title/Abstract] OR “twelve step facilita-
tion”[Title/Abstract] OR “twelve steps”[Title/Abstract] OR
“twelve step”[Title/Abstract] OR “SBIRT”[Title/Abstract]
OR “SBI”[Title/Abstract”))).
Data collection and analysis
Two reviewers (MM and JJ) independently screened the
titles, abstracts, and then full texts to select studies that
met our inclusion criteria. The review authors reconciled
any differences through discussions and consensus at
each stage. MM and JJ who searched the databases and
selected the studies achieved a concordance of 0.63, and
MM and AM who extracted data on risk of bias assess-
ment achieved a concordance of 0.71.
Data extraction
Two reviewers (MM and AM) extracted data independ-
ently using a pre-piloted data extraction form developed
and piloted for this review. Whenever there was any dis-
agreement, the reviewers went through the original arti-
cles until they reached consensus. For each included
study, we extracted the following: (1) general informa-
tion (e.g. ethics approval, funding and study period), (2)
study design, (3) participants, (4) interventions/compara-
tors, (5) outcomes, (6) results and (7) risk of bias
information.
Assessment of risk of bias in included studies
Two reviewers (MM and AM) independently assessed
the risk of bias of the included studies. Differences be-
tween the reviewers were resolved through discussion.
The Cochrane risk of bias tool was used to assess bias in
the included studies [24]. Domains assessed in the risk
of bias assessment included selection bias (adequacy of
sequence generation and allocation concealment), per-
formance bias (blinding of the participants and research
staff) and detection bias (outcome assessors). The other
domains assessed were incomplete/missing outcome
data caused by attrition or loss to follow-up, publication
bias or selective reporting (i.e. where unfavourable or
negative outcomes are not reported) and other bias in-
cluding the influence of funders and other ethical
considerations.
Measure of treatment effect and data synthesis
For binary outcomes, we calculated risk ratios with their
corresponding 95% confidence intervals (CI) where raw
data were reported, otherwise we reported odds ratios
(OR) as reported by the study authors. For continuous
data, we calculated mean differences (MD) and corre-
sponding 95% CI. Both RR and MD were calculated
using Review Manager 5.3 software. Some studies re-
ported intervention effects for continuous outcomes
using Cohen’s d, and we reported the effects as such,
owing to the fact that there were no sufficient data to re-
port the effects as mean differences. As the outcome
measures in individual studies were so diverse, a meta-
analysis could not be performed. Analyses were done
separately for the different types of interventions.
Dealing with missing data
In the case of missing data, we used the available case
analysis. Where there were missing data, intention-to-
treat (ITT) analysis was used.
Assessment of publication biases
We had planned to plot funnel plots to indicate the possi-
bility of publication bias; however, since no meta-analysis
was performed, we did not construct funnel plots.
Subgroup analysis, investigation of heterogeneity and
sensitivity analysis
We had planned to perform a subgroup analysis to iden-
tify potential sources of heterogeneity, as well as under-
take a sensitivity analysis; however, we did not undertake
these as no meta-analysis was performed.
Results
Results of the search
A combined total of 8557 studies were identified
through the various search methods, and after removing
duplicates, 3258 articles remained. After screening titles
and abstracts, full texts of 30 studies were examined and
21 studies with 6954 participants that met the inclusion
criteria were included in the review. The PRISMA dia-
gram (Fig. 1) summarises the results of the search.
Characteristics of included studies
We included 21 studies that assessed alcohol use in
PLWH. All 21 studies were randomised controlled trials.
Eight studies included both men and women [25–31],
three studies included MSM (men who have sex with
men) only [32–34] and four studies included women
only [35–38]. Seven studies employed various forms of
motivational interviewing [19, 26, 29, 30, 32, 33, 39] and
three used cognitive behavioural therapy alone or
blended with motivational interviewing [27–29]. Four
studies evaluated psychological therapies with the
addition of technology [19, 25, 26, 40]. All the studies
used self-report to measure alcohol use. Table 1 shows a
summary of the characteristics of included studies.
Characteristics of excluded studies
There were nine excluded studies. Three studies [45–47]
were not conducted in HIV-positive individuals, two
studies [34, 48] did not include an alcohol use outcome
measure and a single study [49] included young
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adolescents who did not meet age requirements. Two
studies [50, 51] did not include a psychological treat-
ment, and another study [52] was not a randomised con-
trolled trial.
Risk of bias assessment
The results of the risk of bias assessment are sum-
marised in Figs. 2 and 3. Below we briefly report the
results.
Sequence generation
Thirteen studies were judged to be at low risk of bias for
sequence generation [15, 22, 23, 26, 29, 30, 32, 33, 35,
36, 50–52] because the investigators used computer-
generated sequences and run randomisation [53] or SAS
in sequence generation, while for eight studies the risk
was unclear [24, 25, 27, 28, 31, 34, 37, 53]; for example,
Papas et al. [27] stated “randomised” by shuffling “with-
drew from the jar a paper with the name of the condi-
tion”, while Meade et al. [28] and Samet et al. [30] stated
that participants were randomly assigned without
explaining how that was done. The remaining studies
did not report on sequence generation [25, 27].
Allocation concealment
Ten studies were judged as low risk for allocation con-
cealment bias [26, 27, 29, 31, 33, 35, 36, 39, 43, 44] be-
cause the investigators stated that they used sealed
envelopes to conceal the allocations, 10 had unclear risk
[19, 28, 30, 32, 34, 37, 38, 40–42] because they did not
report on how they concealed the allocations to the par-
ticipants and one study was deemed to be high risk [25]
because assignment to the intervention group might
have been deduced by some patients and their providers
through receipt of a computer printout.
Blinding (performance bias)
Five studies [19, 32, 33, 40, 42] were judged to be
low risk of performance bias because the authors
stated that study participants and outcome assessors
were blinded and two studies [26, 35] were at high
risk of performance bias because they stated that they
Fig. 1 PRISMA study flow
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did not blind the investigators, study participants and
outcome assessor. Fourteen studies [25, 27–30, 34,
37–39, 41, 43, 44, 54] were deemed to be of unclear
risk of performance bias because they did not report
on the blinding of researchers, assessors and
participants.
Detection bias
Six studies [19, 32, 33, 35, 40, 42] were judged to be at
low risk of detection bias because they stated that out-
come assessors were blinded. Two studies [26, 37] were
judged to be at high risk of detection bias because the
assessors were not blinded to the treatment assignments
Table 1 Study characteristics
Study ID Study
design
Participants Sample
size
Intervention Comparator Outcome/s
Aharonovich
2017 [19]
RCT Community sample with SU/AU 47 MI/computer
(smartphone)
MI Number of days drunk and number of
drinks per day (TLFB/CIWA-Ar)
Chander 2015
[15]
RCT HIV-positive women with heavy
drinking
148 Brief intervention TAU Frequency of drinking
Dawson-Rose
2017 [40]
RCT 18-year-old HIV positive on
treatment
208 Computer-
administered SBIRT
Physician-
administered
SBIRT
SSIS (alcohol use)
Gilbert 2008
[25]
RCT HIV clinic patients 971 Computer/video call TAU Frequency of drinking
Hasin 2013
[26]
RCT HIV-positive patients consuming
3 or more units of alcohol
295 MI + HealthCall MI Number of drinks in the last 30 days
using TLFB
Kahler 2018
[32]
RCT MSM 180 MI TAU Quantity and Frequency
Meade 2010
[28]
RCT Young people HIV positive 247 CBT-SM Support group Quantity of alcohol
Naar-King
2008 [39]
RCT 16–25-year-old HIV-positive
youths
186 Motivational
interviewing
Waitlist Quantity of alcohol use
Papas 2011
[27]
RCT HIV positive on treatment with
hazardous drinking
75 CBT TAU % drinking days and mean drinks per
day
Parsons 2007
[29]
RCT HIV positive on treatment
hazardous drinkers
143 MI/CBT Health education
condition
Number of drinks per day
Rongkavilit
2013 [41]
RCT Young PLWH 16–25 110 MI Health Education Frequency and quantity of drinking
Rotheram-
Borus 2012
[36]
RCT HIV-positive women 339 Family-based
intervention
Waitlist/TAU Frequency of alcohol use
Samet 2005
[30]
RCT HIV-positive/with alcohol
problems
151 MI TAU Alcohol severity and consumption
Samet 2015
[42]
RCT HIV-positive men with history of
drinking and risk sex
700 Group TAU Quantity and frequency of drinking
Sikkema 2011
[34]
RCT MSM 50 Brief intervention
and standard care
Standard care Frequency of alcohol use
Velasquez
2009 [33]
RCT MSM 253 MI-TTM Referral to other
resources
Quantity, frequency
Wandera 2017
[43]
RCT PLWH AUDIT-C Score 3 or more 982 Brief Intervention Positive
preventive
counselling
AUDIT-C score
Weiss 2011
[37]
RCT HIV-positive women 482 Individual stress-
management SWP II
CBSM/SWPI Miami Alcohol Use Questionnaire
Wong 2008
[31]
RCT HIV positive who engaged in
risk sex
936 Behavioural
intervention
Wait list Number of days drinking
Yu Liu 2018
[44]
RCT Newly diagnosed HIV-positive
men
367 Peer counselling TAU Alcohol consumption and use before
sex
Zule 2014 [38] RCT Women living with HIV 84 Group therapy HCT/Nutrition Number of days abstinent, quantity of
drinking, frequency of drinking
Key: RCT randomised controlled trial, SU/AU substance use/alcohol use, MI motivational interviewing, TAU treatment as usual, SBIRT Screening, Brief Intervention
and Referral To Therapy, PLWH people living with HIV, CBT cognitive behavioural therapy
Madhombiro et al. Systematic Reviews           (2019) 8:244 Page 6 of 16
Fig. 2 Risk of bias assessment
Fig. 3 Risk of bias ratios of included studies
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in these studies, Hasin et al. [26] and Weiss et al. [37].
Thirteen studies [25, 27–31, 34, 38, 39, 41, 43, 44, 54]
were judged to be of unclear risk because they did not
report on the blinding of study outcome assessors or
participants carried out self-assessments.
Incomplete outcome data (attrition bias)
While 13 studies [19, 25–27, 32, 34, 35, 39, 41–44, 54]
were judged to be at low risk of attrition bias because
they had low loss to follow-up, it is important to note
that losses were proportionate in both arms and investi-
gators used intention-to-treat analysis. Six studies [28,
30, 31, 33, 38, 40] had a high risk of attrition bias (high
loss to follow-up), and for two studies [29, 37], it was
unclear whether there was attrition bias: Weiss et al.
[37] stated that “The overall attrition rate for both stud-
ies was approximately 20%” and Parsons et al. [29] indi-
cated that there was a more than 15% loss to follow-up
at 6 months in the two treatment arms.
Selective reporting (reporting bias)
All 21 studies were judged to be at low risk of selective
reporting in this review because all outcomes (as de-
scribed in “Methods”) were reported in the results.
Other potential sources of bias
There was no reason to suspect other biases in the stud-
ies included in the review.
Effects of interventions
The studies assessed the intervention effects using vari-
ous measures. Table 2 shows the assessed outcomes.
Comparison 1: Motivational interviewing (MI) versus
control
Seven studies assessed this comparison [26, 29, 30, 32,
33, 39, 41].
Primary outcome
Alcohol use
Quantity of alcohol use The studies that reported on
the quantity of alcohol use did so using different out-
comes that did not allow for a meta-analysis. We, there-
fore, report on the results of individual studies. Kahler
et al. [32] found that participants in the motivational
interviewing group drank significantly fewer drinks per
week compared with the control group at the end of the
6-month treatment period (Cohen’s d = − 0.33, p < 0.04)
[32]. Other studies consistently reported similar effects
in the quantity of alcohol use between motivational
interviewing and control groups: Velasquez et al. [33]
found no significant difference in the average number of
drinks per drinking day between motivational
interviewing and control groups (OR 1.04, 95% CI 0.77
to 1.40); Naar-King et al. [39] measured most standard
drinks in 1 week but found no significant difference in
the log-transformed 6-month follow-up change scores
between the two treatment groups (MD − 0.36, 95%CI −
0.84 to 0.12, n = 49); and Parsons et al. [29] also reported
no significant difference in the number of drinks per
drinking day at 6 months [29, 33, 39].
Frequency of alcohol use A number of studies mea-
sured this outcome; however, the results were reported in
different ways that did not allow for a pooling of the data.
Kahler et al. [29] found that participants in the motiv-
ational interviewing intervention had significantly fewer
drinking days per month (Cohen’s d = − 0.40, p < 0.01),
compared to the control group. Hasin et al. [26] found
that participants in the motivational interviewing group
had a similar number of drinking days as the control
group during a 60-day period (MD − 0.71 days, 95%CI −
1.73 to 0.11, n = 170), and Rongkavilit et al. [41] also found
that participants in the motivational interviewing group
had a similar number of drinking days in past 30 days at 6
months as the control group (Mean(SD)[n] was
1.0(1.7)[n = 49] for intervention and 0.9 (1.5) [n = 42] for
control) [26, 32, 41].
Secondary outcomes
Reduction in viral load
The results could not be pooled and we report on
them individually. All the studies consistently showed
similar effects on the reduction in viral load between
the intervention and control groups: Kahler et al. [32]
found a similar number of participants having detect-
able viral load (% > 75cp/mL) between the motiv-
ational interviewing and control groups at 12 months
(RR 0.68, 95% CI 0.20 to 2.33; n = 180); Rongkavilit
et al. [41] found no significant difference in viral load
(log10 copies/ml) at 6 months post session between
motivational interviewing and control groups (MD
0.10, 95%CI − 0.53 to 0.73, n = 39); Naar-King et al.
[39] measured log viral load from baseline to 6
months, and there was no significant difference be-
tween motivational interviewing and control groups
(MD − 1.23, 95%CI − 2.48 to 0.03, n = 46); and Par-
sons et al. [29] also found no significant differences
in log viral load between the two treatment groups at
6 months, according to study authors [29, 32, 39, 41].
CD4 count
The two studies reporting this outcome found similar
effects on CD4 count between the motivational inter-
viewing and control groups: Kahler et al. [32] found
no significant difference in CD4 count between the
motivational interviewing and control groups at both
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Table 2 The outcome data of the included studies
Study ID Alcohol use measure Viral load
measure
CD4 Adherence Risky sexual behaviour Quality of
life
Aharonovich
2017 [19]
Frequency (IRR = 0.67, 95%
CI = 0.41–1.07).
Quantity (IRR = 0.63 (95%
CI = 0.36–1.11)
– – – – –
Chander
2015 [35]
Less likely to have a drinking
day (OR 0.42 (95% CI 0.23–
0.75) (p = 0.005).
90-day drinking frequency in
the intervention group was
4.6 [95% CI 0.9, 7.1]
Intervention effect 2.9 [95%
CI 0.8, 4.4]
Odds ratio 1.30
95% CI 0.65–
2.61).
– (OR 1.11 95%
CI (0.853,
1.447)
(p = .43)).
No diff.
Odds of having unprotected
vaginal sex compared with the
usual care group (AOR = 0.386 with
95% CI (0.156, 0.952), p = 0.041)
–
Dawson-
Rose 2017
[40]
− 1.59 (95% CI − 2.19, − 1.00) – – – – –
Gilbert 2008
[25]
Any drinking at 3 months RR
0.84 (0.651, 1.080) p = 0.172
Any drinking at 6 months RR
0.87 (0.666, 1.130) p = 0.291
Risk of drinking at 3 month
RR 0.88 (0.628, 1.220) p =
0.432
Risk of drinking at 6 months
0.85 (0.606, 1.191) p = 0.343
– – – Unprotected sex (RR 0.88, 95% CI
0.773, 0.993, p = 0.039 at 3 months;
and RR 0.80, 95% CI 0.686, 0.941,
p = 0.007 at 6 months)
–
Hasin 2013
[26]
χ2, d.f. = 9.11,2, p = 0.01) – – – – –
Kahler 2018
[32]
Quantity of alcohol use
Cohen’s d − 5.0 p < .001 at 6
months and − 3.3 p < 0.04 at
12 months
Frequency
d = −.42 p < 01 and .40
p < .01 at 12 months
d = .02 p = .99 at
6 months and
d = − .11 p = .72
at 12 months
d = −.25 p = .08
at 6 months and
d = −.21 p = .15
at 12 months
– Condomless sex d = −.08 p = .79 at
6 months and d = −.19 p = .10
Sex under influence
d = −.04 p = .20 at 6 months and
d = −.09 p = .11 at 6 months
–
Meade 2010
[28]
Quantity (Wald χ2(4) = 10.77,
p < .05)
– – – – –
Naar-King
2008 [39]
t(48) = 1.65, p = .05 t(45) = 1.91,
p = .03
– t(47) = .53, p = .30 –
Papas 2011
[27]
Percentage daily drinking
(d = .95, p = .0002, mean
difference = 24.93 (95% CI
12.43, 37.43)
Drinks per drinking day
(d = .76, p = .002, mean
difference = 2.88 (95% CI
1.05, 4.70)
– – – – –
Parsons 2007
[29]
Standard drinks from
baseline to 3 months [F(1,
112) = 62.7; p < 0.001]
6-month follow-up [F(1,
93) = 48.7; p < 0.001]
(OR = 2.7; p =
0.03)
[F(1, 115) = 6.44;
p < 0.02]
OR = 3.4; p =
0.013)
Percent dose
adherence
[F(1, 107) =
13.5; p <
0.001]
[F(1, 111) =
21.9; p <
0.001]
– –
Rongkavilit
2013 [41]
Frequency S = − 0.64, p =
0.52
S = − 0.84, p = 0.40
Quantity S = − 0.33, p = 0.74
S = − 0.79, p = 0.43
t = 0.75, p = 0.47
t = − 0.14, p =
0.89
– S = − 0.85,
p = 0.40
S = − 0.71,
p = 0.48
– Condom
use t = −
0.87, p =
0.39
t = − 1.92,
p = 0.06
Avoiding
multiple
partners
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6 months (Cohen’s d = − 0.25, p = 0.08) and 12 months
(Cohen’s d = − 0.21, p = 0.15), and Parsons et al. [29]
also found no significant differences between the two
treatment groups at 6 months.
ART adherence
The two studies reporting this outcome found similar ef-
fects on ART adherence between the motivational inter-
viewing and control groups: Rongkavilit et al. [41] found
Table 2 The outcome data of the included studies (Continued)
Study ID Alcohol use measure Viral load
measure
CD4 Adherence Risky sexual behaviour Quality of
life
t = − 1.00,
p = 0.32
t = − 1.64,
p = 0.11
HIV
disclosure
to partners
t = − 0.18,
p = 0.86
t = − 0.83,
p = 0.41
Rotheram-
Borus 2012
[36]
t = − 3.46, df = 256, p < 0.01 63% had an
undetectable
viral load
– Adherence
76%
– –
Samet 2005
[30]
No effect on frequency,
quantity
p > 0.25
No effect
p > 0.25
No effect p >
0.25
No effect
p > 0.25
– –
Samet 2015
[42]
Quantity OR 1.05 (0.77,
1.43)p = 0.76
AOR 1.04 (0.77, 1.40)
p = 0.80
Frequency OR 1.00 (0.72,
1.40)
p = 0.98
AOR 1.00 (0.72, 1.39)
p = 1.00
Needle sharing
OR 1.12 (0.75,
1.69) p = 0.58
AOR 1.13 (0.74,
1.73)
p = 0.56
Distributive
needle sharing
OR 1.18 (0.75,
1.86) p = 0.47
AOR 1.20 (0.76,
1.91)
p = 0.43
– – STI OR 0.65 (0.35, 1.19) p = 0.16
AOR 0.63 (0.34, 1.18) p = 0.15
Decrease in unprotected sex OR
0.91 (0.69, 1.20
p = 0.50
AOR 0.91 (0.69, 1.20)
p = 0.51
–
Sikkema
2011 [34]
Mean diff. (MD Interv.0.17)
(MD Control 0.04 (0.13)
– – 62.1% at
baseline and
57.1% at 6
months
MD 0.16 (− 0.28) 0.44 –
Velasquez
2009 [33]
(Odds ratio [OR] = 1.38; 95%
confidence interval [CI] =
1.02–1.86)
Higher number of heavy
drinking days per 30-day
period by a factor of 1.5
(OR = 1.5; 95% CI = 1.08–2.10)
– – – χ2(33, N = 216) = 67.5, p < .001
2.19 (OR = 2.19; 95% CI = 1.17–4.11).
–
Wandera
2017 [43]
Mean AUDIT-C difference of
the differences = − 0.07, 95%
CI − 0.70–0.56, p = 0.8266
– – – – –
Weiss 2011
[37]
Miami Alcohol Use
Questionnaire
(F[2486] = 3.39, p < 0.05)
Reduction
significant (p <
0.01)
– (t[44] = 3.08,
p < 0.01)
(p < 0.05)
Wong 2008
[31]
(t = − 15.4, df = 935, p <
0.0001)
(alcohol and marijuana)
– – – – –
Liu YU 2018
[44]
23 to 9% (p = 0.001) – – – 50 to 16% (p < 0.001) –
Zule 2014
[38]
(Odds ratio [OR] = 3.61; 95%
confidence intervals [CI] =
1.23, 11.70; p = 0.016)
– – – – –
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no significant difference in ART adherence at 6 months
(RR 1.02. 95%CI 0.82 to 1.26, n = 39) and Parsons et al.
[29] measured ART adherence in terms of percent dose
adherence but found no significant difference between
the two treatment groups at 6 months (MD 5.30%,
95%CI − 7.41 to 18.01%, n = 115) [29, 41].
Risky sexual behaviour
Naar-King et al. [39] measured the number of unpro-
tected sex acts, but there was no significant difference in
the log-transformed 6-month follow-up change scores
between the two treatment groups (MD 0.09, 95%CI −
0.54 to 0.72, n = 48) [32, 39].
Comparison 2: Cognitive behavioural therapy (CBT)
versus control
One study Papas et al. [27] assessed this comparison
[27].
Primary outcome
Alcohol use
Frequency of alcohol use Papas et al. [27] found that
participants in the CBT intervention group experienced
a significantly greater reduction in the percentage of
drinking days in the previous 30 days at the end of 90
days of treatment (MD − 16.92%, 95%CI − 30.46 to −
3.38%, n = 68) [27].
Secondary outcomes
Papas et al. [27] did not measure any secondary out-
comes [27].
Comparison 3: Brief intervention (BI) versus treatment as
usual (TAU)
Four studies assessed this comparison [31, 34, 35, 43].
Primary outcome
Alcohol use
Quantity of alcohol use The two studies reporting this
outcome found no significant effect for the brief inter-
vention compared to the control group; Chander et al.
[35] found no significant difference in the average num-
ber of drinks per drinking day between the brief inter-
vention and control groups (RR 0.92, 95%CI 0.68 to
1.24, p = 0.586, n = 112); Wandera et al. [43] measured
alcohol consumption outcomes using change in Alcohol
Use Disorders Identification Tool (AUDIT-C) scores but
found no significant difference at the end of the treat-
ment period at 6 months (MD 0.50, 95%CI − 0.16 to
1.16, n = 320) [35, 43].
Frequency of alcohol use
Chander et al. [35] documented a similar 90-day fre-
quency of binge drinking in the brief intervention and
control groups (OR 0.60, 95%CI 0.24 to 1.54, p = 0.293,
n = 112) [35].
Secondary outcomes
Reduction in viral load
Chander et al. [35] measured viral suppression (HIV-1
RNA < 50) and found no significant difference between
the brief intervention and control groups at 12 months
(OR 1.30, 95%CI 0.65 to 2.61, n = 148), as reported by
study authors [35].
ART adherence
Chander et al. [35] measured antiretroviral adherence
among the HIV-positive women but found that a brief
intervention failed to significantly improve appointment
adherence (defined as number of completed visits defined
by total scheduled visits) (OR 1.11, 95%CI 0.85 to 1.45,
p = 0.43, n = 148), as reported by study authors [35].
Risky sexual behaviour
Chander et al. [35] reported that a brief intervention sig-
nificantly reduced the likelihood of having unprotected va-
ginal sex compared to the usual care group (adjusted odds
ratio (aOR) 0.39, 95%CI 0.16 to 0.95, p = 0.041, n = 148),
after adjusting for baseline number of days of unprotected
sex, as reported by study authors [35].
Comparison 4: Computer/technology versus treatment as
usual (TAU)
Four studies assessed this comparison [19, 25, 26, 40].
Primary outcome
Alcohol use
Quantity of alcohol use Aharonovich et al. [19] com-
pared MI + HealthCall technology versus Attention/
Education control and found no significant difference in
the number of drinking days during the 60-day period
(MD − 1.10, 95%CI − 5.16 to 2.96; n = 42) [19].
Frequency of alcohol use Aharonovich et al. [19] found
no significant difference in number of standard drinks
per day at the end of 60 days of treatment (MD − 0.40,
95% CI − 1.04 to 0.24; n = 42) [19].
Comparison 5: Group versus TAU/wait list/nutritional
Seven studies assessed this comparison [28, 36–38,
42, 44, 54].
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Primary outcome
Alcohol use
Quantity of alcohol use Samet et al. [42] measured
average drinks per day but found no significant differ-
ence between treatment groups (adjusted odds ratio
[aOR] 1.04, 95%CI 0.77 to 1.40, p = 0.80), according
to study authors [42]. Meade et al. [28] measured the
reduction in the number of drinks per month from
baseline to 12 months and found no significant differ-
ence between the ‘coping group’ compared to a sup-
port/control group (MD 3.50, 95%CI − 1.98 to 8.98,
n = 247). Rotheram-Borus et al. [54] assessed mothers
living with HIV and their school-going adolescent
children using a family-focussed cognitive behavioural
group intervention [36]. Among the mothers living
with HIV who were using alcohol, those in the inter-
vention unexpectedly drank more than those in the
control group (p < 0.01) [36].
Frequency of alcohol use Zule et al. [38] found that a
greater proportion of participants in the intervention
group were abstinent from alcohol compared to the con-
trol group (RR 2.57, 95%CI 1.20 to 5.50, n = 84) [38].
Secondary outcomes
ART adherence
Weiss et al. [37] SWP II study reported that participants
in the intervention group significantly increased ARV
adherence compared to the control group (p < 0.05) [37].
Risky sexual behaviour
Weiss et al. [37] SWP II study reported that the odds of
having unprotected sex were significantly reduced in the
intervention group compared to the control group (p <
0.038) [37]. Samet et al. [42] found no significant differ-
ence in the change over time in unprotected sex acts
(aOR 0.91, 95%CI 0.69, 1.20), any needle sharing (aOR
1.13, 95%CI 0.74 to 1.73, p = 0.51) or STIs (aOR 0.63,
95%CI 0.34 to 1.18, p = 0.15) between the two treatment
groups [42]. In the Liu et al. [44] study, the intervention
reduced the risk of insertive anal sex (aOR 0.65, 95%CI
0.45 to 0.94), condomless anal sex (aOR 0.27, 95%CI
0.10 to 0.74) and illicit drug use (aOR 0.32, 95%CI 0.16
to 0.64), compared to standard of care, at 12-month
follow-up [44].
Discussion
This systematic review aimed to synthesise studies that
have investigated the effectiveness of psychological inter-
ventions for AUDs in PLWH. We identified 21 studies
that met our inclusion criteria. Owing to significant het-
erogeneity across studies in the populations studied, the
interventions tested, and the outcome measures
administered, no meta-analysis could be performed. The
included studies were randomised controlled trials of
PLWH: women only, MSM, mixed gender and adoles-
cents and young adults. Studies aimed at reducing alco-
hol use in PLWH employed a variety of interventions
that included motivational interviewing, CBT, brief in-
terventions, mobile/technology aided treatments and
group therapies.
Three previous systematic reviews have reported on
the effectiveness of psychological/behavioural interven-
tions on alcohol use in PLWH, published in 2010 [55],
2013 [16] and 2017 [56]. All but one [56] of these con-
cluded that psychological/behavioural interventions were
effective for problematic alcohol use in PLWH. New
studies have since emerged that address alcohol use in
the context of HIV treatment and have been included in
this review [2, 26, 38]. In this synthesis, there were no
consistent findings of intervention effect for motivational
interviewing, compared to a control, on the quantity and
frequency of alcohol use, with the exception of the study
by Kahler et al. [32]. Papas et al. [27] assessed the effects
of cognitive behavioural therapy on the frequency of al-
cohol consumption and found a significant treatment ef-
fect [27]. Neither studies that delivered a brief
intervention nor those that administered a technology
assisted intervention found significant treatment effects
on the quantity and frequency of alcohol use. Of the
studies that delivered group therapy, only Zule et al. [38]
found intervention effects on alcohol use. Another study
documented an increase in the quantity of alcohol con-
sumed in the intervention group [38]. Similarly, second-
ary outcomes were also heterogeneous and measured in
a non-uniform manner across studies, and we were not
able to pool data to examine intervention effects on
these outcomes.
Across the studies, populations included were di-
verse. Treatment response may be a function of gen-
der, age and ART adherence. Alcohol users compared
to multiple substance users may also respond differ-
ently. Some of the interventions were delivered in the
community and yet others were delivered at clinics or
were hospital based. The context may also affect re-
sponse to an intervention. Although PROJECT Match
was a large study that found that outcomes did not
differ by intervention type (motivational enhancement
therapy, cognitive behavioural therapy and Twelve-
Step Facilitation), the findings of PROJECT Match
may not be applicable to diverse HIV-infected popula-
tions [57, 58]. Aside from the different theoretical
foundations of the aforementioned interventions, dif-
ferences in treatment duration, number of sessions
and delivery agents may contribute to the differences
in outcomes recorded in the studies included in this
review.
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In addition, different measures of alcohol use were
employed. Some studies elected to assess the quantity of
alcohol consumed within a certain timeframe while
other studies assessed the frequency of alcohol con-
sumption. All studies used self-report screeners that are
limited by social desirability bias. Few of the studies
assessed viral load and CD4 count change, and for those
that did, they did not find intervention effects. Alcohol
use is also a dynamic behaviour, and change in the pat-
tern of use due to intervention may not have been
present long enough to lead to enduring change in viral
load and/or CD4 count. Further, CD4 count measured
at baseline may not be a good predictor of change and
CD4 nadir maybe a better predictor of future CD4
change [59, 60]. The adherence measures in the studies
reviewed were self-report or pill count, but these have
also been shown to be unreliable, with antiretroviral
drug levels being a better and more reliable assessment
of adherence.
HIV infection is associated with other social challenges
such as poverty, unemployment and isolation, and all
have been shown to independently influence treatment
outcomes [61]. Apart from these social factors, mental
disorders such as depression, anxiety and posttraumatic
stress disorder (PTSD) are common comorbidities and
can influence treatment response [62]. Depression, anx-
iety and PTSD are associated with alcohol use, with re-
search findings suggesting a shared neurobiological basis
prompting recommendations for transdiagnostic inter-
ventions that target alcohol use, adherence and these
mental disorders [63]. Further, psychosocial interven-
tions for alcohol and depression may also work for
dually diagnosed patients [64]. Complications of alcohol
use include liver damage, hepatocellular carcinoma and
hepatitis C, and these can all affect an individual’s ability
to metabolise antiretroviral drugs and can increase the
propensity to adverse effects [65–67].
A number of limitations deserve mention. Most im-
portant is the lack of standardised measures of alcohol
use outcomes, whether frequency or quantity. Biochem-
ical measures of alcohol use, such as the gamma glutaryl
transferase, phosphotidyl ethanol or mean corpuscular
volume, are recommended, in addition to self-report in-
struments. Given that the effects of alcohol on PLWH
are not only related to effects on adherence, risky sexual
behaviours and virological control, but are also associ-
ated with immunosuppressant and deleterious effects on
the liver, these outcomes need to be included as treat-
ment targets. Further, the studies in this review included
participants with different levels of alcohol use which
may affect the effects of an intervention. More severe
users, including those with dependency, may require dif-
ferent doses of an intervention and perhaps adjunctive
pharmacological therapies.
Our search was recent and comprehensive and encom-
passed electronic searches of key databases and a search
of reference lists of included studies and relevant reviews
for additional studies. It is unlikely that any studies were
missed. To reduce the potential for bias, two review au-
thors independently undertook the selection of studies,
extraction of data and assessment for the risk of bias.
We could have obtained more data if we had contacted
authors and requested additional data, but it was not
possible owing to time constraints. Finally, using GRA-
DEpro to assess the quality of evidence would have given
more robust results; however, the heterogeneity in out-
comes made it difficult to tease out outcomes for inclu-
sion using GRADEpro [65].
To our knowledge, this is the fourth systematic review
to assess the evidence for psychological interventions for
AUDs in PLWH. Brown et al. [21] raised similar con-
cerns pertaining to the selection of outcome measures
and the variation in study methodologies in their review.
A review by Samet et al. [64] found limited evidence for
the effectiveness of behavioural interventions, a finding
replicated in this review. However, a recent review by
Scott-Sheldon et al. [56] found behavioural interventions
to be effective in reducing alcohol consumption, risky
sexual behaviour and viral load in PLWH. Our review
compared with that of Scott-Sheldon employed a
broader search strategy, included more recent studies
and rigorously assessed the risk of bias assessment [56].
We believe our findings are consistent with previous re-
views in finding little evidence for effectiveness of psy-
chological interventions for AUDs in PLWH.
Conclusion
This systematic review did not reveal large or sustained
intervention effects of psychological interventions for ei-
ther primary alcohol use or secondary HIV-related out-
comes. Owing to a high degree of methodological
heterogeneity, a meta-analysis was not performed. Our
review did not reveal significant intervention effects for
both primary and secondary outcomes. There is, there-
fore, a need for effectiveness studies of psychological in-
terventions for AUDs in PLWH in samples that include
analyses that are disaggregated by the level of alcohol
consumption, gender and age. Further, there is need to
standardise alcohol use outcome measures across studies
and include biomarkers, as the majority of studies have
used self-report assessments that are prone to social de-
sirability bias. Studies should also take the presence of
comorbidities, such as depression, into account as they
are likely to impact on intervention outcomes.
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